[1]
2025. Molecular Docking Study of Nigella sativa Alkaloid Compounds as the Inhibitor of Papain-Like Protease SARS-CoV-2. Journal of Tropical Pharmacy and Chemistry . 7, 1 (Feb. 2025), 33–40. DOI:https://doi.org/10.30872/j.trop.pharm.chem.v7i1.148.